Samsara Bio Capital, LLC Nkarta, Inc. Transaction History
Samsara Bio Capital, LLC
- $326 Million
- Q4 2024
A detailed history of Samsara Bio Capital, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 3,768,035 shares of NKTX stock, worth $8.55 Million. This represents 2.88% of its overall portfolio holdings.
Number of Shares
3,768,035
Previous 3,768,035
-0.0%
Holding current value
$8.55 Million
Previous $17 Million
44.91%
% of portfolio
2.88%
Previous 9.87%
Shares
5 transactions
Others Institutions Holding NKTX
# of Institutions
119Shares Held
61.3MCall Options Held
17.6KPut Options Held
1.11M-
Ra Capital Management, L.P. Boston, MA10.8MShares$24.5 Million0.44% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$9.21 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$8.1 Million0.63% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.56MShares$8.09 Million0.0% of portfolio
-
Sr One Capital Management, LP3.33MShares$7.57 Million3.09% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $110M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...